cretostimogene
Phase 3- Indications
- Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer
Company intelligence / Profile preview
The company developed and commercialized non-invasive mechanical compression devices for DVT/VTE prevention, notably the ActiveCare® system with patented synchronized flow technology. Their solutions were proven to reduce bleeding complications compared to pharmaceutical prophylaxis, improve patient compliance via mobile monitoring apps, and lower hospital costs for joint replacement patients. The company was acquired by Zimmer Biomet in May 2017.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medical Compression Systems.